- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03864874
Use of Thoracoscopic Intraoperative Lung Ultrasound to Identify Pulmonary Metastases in Patients Submitted to Pulmonary Metastasectomy With Radical Intent. (VATS-US1)
Thoracoscopic Ultrasonography Versus Manual Lung Palpation by Thoracotomy for the Identification of Lung Nodules During Pulmonary Metastasectomy. A Prospective Blinded Cross-over Trial.
Experience drawn from many scientific articles showed that many patients who develop a limited pattern of pulmonary metastases after treatment of a primary tumor may benefit from surgical resection of the lung deposits. Pulmonary metastasectomy with curative intent is widely performed with the aim of prolonging life and, in some cases, being curative. Usually the surgical strategy is defined based on analysis of radiological investigations, performed during a follow-up program after resection of a tumor. However, many studies showed that the actual sensitivity of this examinations, namely computed tomography (CT) and positron-emission tomography (PET) is far from being 100% and finding further unexpected nodules at operation with lung manual palpation is not uncommon. Many surgeons perform pulmonary metastasectomy with a minimally invasive approach, in view of a less morbid and more cosmetic approach, but lung palpation is considerably hampered and surgical radicality might be impaired. With this study the investigators want to assess the ability of lung ultrasonography performed via a key-hole access (thoracoscopy, VATS) in detecting lung nodules compared with the standard practice represented by open thoracotomy, that is a wider incision that allows manual exploration of the organ. Therefore, every patient enrolled will undergo a double phase surgical approach: a first phase by thoracoscopy where a thorough lung ultrasonography will be performed and number and position of lung nodules will be annotated, and a second phase by open thoracotomy where lung is palpated and suspicious nodules will be removed. The incisions used for the first phase will be extended for the second, rendering any other procedure for the execution of lung ultrasonography unnecessary.
Should this study demonstrate a non-inferiority of lung ultrasonography in detecting lung nodules compared with manual palpation of the lung, patients should be offered a less invasive approach for treatment of their condition with no concerns regarding a potential lower therapeutic effect.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pulmonary metastasectomy is a surgical practice that poses many aspects of debate: standard approach has historically been represented by open thoracotomy, but video-assisted thoracic surgery (VATS) became an appealing alternative due to the lower surgical impact on the patient. Some authors blame the minimally invasive approach for pulmonary metastasectomy as less effective from an oncologic point of view since lung palpation is hampered, leading to reduced ability to identify unexpected nodules and potential impairment of surgical radicality.
Indeed, several papers demonstrated a suboptimal sensitivity of computed tomography (CT) and positron-emission tomography (PET) in detecting lung metastases and discover of further unexpected nodules at thoracotomy are not an uncommon eventuality.
A few authors demonstrated the utility of intraoperative lung ultrasound performed through a VATS approach (VATS-US) in identifying lung nodules. However, the real effectiveness of this technique has never been prospectively compared with the current gold standard represented by open thoracotomy and lung manual exploration. Aim of our study is to assess the non-inferiority of VATS-US compared with manual palpation to identify lung nodules during pulmonary metastasectomy.
The study design is a monocentric non-inferiority diagnostic crossover trial, based on the execution of intraoperative lung ultrasound (VATS-US) in patients undergoing pulmonary metastasectomy with radical intent. Aim of the study is to assess the non-inferiority of the ultrasonographic investigation on the lung parenchyma performed via a thoracoscopic approach in identifying lung nodules compared with manual organ palpation by thoracotomy.
Study design After general anesthesia administration patients will be intubated with a double lumen tube and positioned in a standard lateral decubitus. Thereby the target lung will be excluded from ventilation and deflated. After creation of 2-3 thoracoscopic ports the lung is explored under thoracoscopic vision with a laparoscopic ultrasound probe (Esaote LP323, Esaote, Genova, Italy) by a surgeon with experience on the use of lung ultrasound. Data regarding number, size, depth and lobar localization of nodules are registered on a data collection paper. The surgeon who performed the investigation therefore leaves the operative room and another surgeon, blind to the previous phase findings, performs an anterolateral thoracotomy and an accurate palpation of the lung. Suspicious nodules are therefore resected and sent for histology. Data on number and localization of excised nodules are registered on a separate collection paper. Results from both phases are then compared and matched with histology report.
Thoracotomy will be performed extending the length of the utility port. The others 1-2 hole are eventually used for insertion of chest drainage tubes, that in our institution are routinely positioned following any intervention within the pleural space. Consequently, no adjunctive incision will be performed for the execution of VATS-US compared with a standard thoracotomy approach. Only after nodules resection the two surgeons will compare their findings in order to make sure that any nodule identified at VATS-US but not at thoracotomy has not been omitted. The execution of the ultrasonographic investigation will require an appropriate lung deflation. Therefore, in some cases air aspiration from the target lung with a small catheter inserted through the endobronchial tube will be required, as previously described in other studies.
In order to guarantee patients' safety, they will never be left unattended during all phases of the intervention, and execution of any required urgent procedure for rare intraoperative complications will never be delayed, including those that may interfere with the execution of the ultrasonographic exam. It has been calculated that operative time will be extended of about 20-30 minutes to allow the execution of VATS-US.
No extra procedure or drugs administration will be required for the study. Only nodules that will be considered suspicious by the second surgeon during the thoracotomic phase or after discussion between the two operators will be excised, as expected in the standard practice.
The investigators will collect data regarding patients' features (age, biometric measurements, preoperative lung function tests data, lung comorbidities), preoperative CT scan findings (number, size and localization of lung nodules), ultrasonographic findings (number, size, depth, localization and shape of lung nodules), number and localization of nodules excised at thoracotomy, histology report data (histological nature, size, depth of lung nodules), time of surgery and of VATS-US, incidence of post-operative adverse events.
Sample size and statistical analysis Sensitivity and specificity of VATS-US will be calculated compared with manual palpation. The inter-rater agreement will be measured by calculating Cohen's kappa coefficient. Continuous data will be summarized as mean and standard deviation or median and twenty-fifth to seventy-fifth percentiles in case of non-normal distributions. Normality will be assessed by using Shapiro-Wilk test. Categorical variables will be reported as counts and percentages. Comparisons will be carried out using paired t-test, Wilcoxon signed ranks test and McNemar test where appropriate.
STATA software (release 14 StataCorp LP, College Station, TX, USA) will be utilized for analysis.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: francesco londero, MD
- Phone Number: +390432554069
- Email: francesco.londero@asuiud.sanita.fvg.it
Study Locations
-
-
Ud
-
Udine, Ud, Italy, 33100
- Recruiting
- Thoracic Surgery Unit, Cardiothoracic Dept., ASUI S Maria della Misericordia
-
Contact:
- francesco londero
- Phone Number: 00390432554069
- Email: francesco.londero@asuiud.sanita.fvg.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient candidate to pulmonary metastasectomy with curative intent by mean of both major anatomical or limited resection;
- Age > 18 years.
Exclusion Criteria:
- Patients with widespread metastatic disease where surgical resection is performed only for diagnostic purposes;
- History of previous intrapleural talc injection;
- Any anatomical or pathological condition (eg. diffuse adhesions, severe emphysema) that may interfere with execution of ultrasonographic investigation;
- Incomplete lung exclusion during surgical procedure.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of nodules/lesions identified: surgery
Time Frame: Intraoperative
|
Number of nodules identified at VATS-US and lung palpation/ number of lesions identified at lung palpation
|
Intraoperative
|
Number of nodules/lesions identified: histology
Time Frame: Up to 2 weeks
|
Number of nodules identified at VATS-US and lung palpation/ number of lesions confirmed to be pulmonary metastases
|
Up to 2 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Francesco Londero, MD, Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine
- Study Director: Angelo Morelli, MD, Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine
- Study Chair: Sandro Gelsomino, MD, PhD, FESC, Cardiothoracic Department Maastricht University Hospital, Maastricht, The Netherlands
- Study Chair: Luigi Castriotta, MD, Clinical Epidemiology Department, ASUI S Maria della Misericordia, Udine
- Study Chair: William Grossi, MD, Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine
- Study Chair: Gianluca Masullo, MD, Thoracic Surgery Unit, ASUI S Maria della Misericordia, Udine
Publications and helpful links
General Publications
- Lobo V, Weingrow D, Perera P, Williams SR, Gharahbaghian L. Thoracic ultrasonography. Crit Care Clin. 2014 Jan;30(1):93-117, v-vi. doi: 10.1016/j.ccc.2013.08.002.
- Mattioli S, D'Ovidio F, Daddi N, Ferruzzi L, Pilotti V, Ruffato A, Bolzani R, Gavelli G. Transthoracic endosonography for the intraoperative localization of lung nodules. Ann Thorac Surg. 2005 Feb;79(2):443-9; discussion 443-9. doi: 10.1016/j.athoracsur.2004.07.087.
- Molnar TF, Gebitekin C, Turna A. What are the considerations in the surgical approach in pulmonary metastasectomy? J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S140-4. doi: 10.1097/JTO.0b013e3181dcf62c.
- Ellis MC, Hessman CJ, Weerasinghe R, Schipper PH, Vetto JT. Comparison of pulmonary nodule detection rates between preoperative CT imaging and intraoperative lung palpation. Am J Surg. 2011 May;201(5):619-22. doi: 10.1016/j.amjsurg.2011.01.005.
- Eckardt J, Licht PB. Thoracoscopic or open surgery for pulmonary metastasectomy: an observer blinded study. Ann Thorac Surg. 2014 Aug;98(2):466-9; discussion 469-70. doi: 10.1016/j.athoracsur.2014.04.063. Epub 2014 Jun 11.
- Macherey S, Doerr F, Heldwein M, Hekmat K. Is manual palpation of the lung necessary in patients undergoing pulmonary metastasectomy? Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):351-9. doi: 10.1093/icvts/ivv337. Epub 2015 Dec 17.
- Piolanti M, Coppola F, Papa S, Pilotti V, Mattioli S, Gavelli G. Ultrasonographic localization of occult pulmonary nodules during video-assisted thoracic surgery. Eur Radiol. 2003 Oct;13(10):2358-64. doi: 10.1007/s00330-003-1916-6. Epub 2003 May 8.
- Rocco G, Cicalese M, La Manna C, La Rocca A, Martucci N, Salvi R. Ultrasonographic identification of peripheral pulmonary nodules through uniportal video-assisted thoracic surgery. Ann Thorac Surg. 2011 Sep;92(3):1099-101. doi: 10.1016/j.athoracsur.2011.03.030.
- Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, Johnston M, McCormack P, Pass H, Putnam JB Jr; International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49. doi: 10.1016/s0022-5223(97)70397-0.
- Vannucci F, Gonzalez-Rivas D. Is VATS lobectomy standard of care for operable non-small cell lung cancer? Lung Cancer. 2016 Oct;100:114-119. doi: 10.1016/j.lungcan.2016.08.004. Epub 2016 Aug 11.
- Internullo E, Cassivi SD, Van Raemdonck D, Friedel G, Treasure T; ESTS Pulmonary Metastasectomy Working Group. Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol. 2008 Nov;3(11):1257-66. doi: 10.1097/JTO.0b013e31818bd9da.
- Ujiie H, Kato T, Hu HP, Hasan S, Patel P, Wada H, Lee D, Fujino K, Hwang DM, Cypel M, de Perrot M, Pierre A, Darling G, Waddell TK, Keshavjee S, Yasufuku K. Evaluation of a New Ultrasound Thoracoscope for Localization of Lung Nodules in Ex Vivo Human Lungs. Ann Thorac Surg. 2017 Mar;103(3):926-934. doi: 10.1016/j.athoracsur.2016.08.031. Epub 2016 Oct 17.
- Gossot D, Radu C, Girard P, Le Cesne A, Bonvalot S, Boudaya MS, Validire P, Magdeleinat P. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg. 2009 Jan;87(1):238-43. doi: 10.1016/j.athoracsur.2008.09.036.
- Londero F, Castriotta L, Grossi W, Masullo G, Morelli A, Tetta C, Livi U, Maessen JG, Gelsomino S. VATS-US1: Thoracoscopic ultrasonography for the identification of nodules during lung metastasectomy. Future Oncol. 2020 Feb;16(5):85-89. doi: 10.2217/fon-2019-0608. Epub 2020 Jan 9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 30948
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Metastases
-
The First Affiliated Hospital of Guangzhou Medical...UnknownPulmonary Metastases | NSCLCChina
-
Masonic Cancer Center, University of MinnesotaWithdrawnPulmonary Metastases | Metastatic Melanoma | Brain Metastases | Hepatic MetastasesUnited States
-
University of PittsburghRITA Medical SystemsSuspendedPulmonary Metastases | NSCLCUnited States
-
Ruijin HospitalActive, not recruitingPulmonary Metastases | Osteosarcoma | ApatinibChina
-
Karolinska University HospitalKarolinska InstitutetActive, not recruiting
-
Royal Marsden NHS Foundation TrustImperial College London; Royal Brompton & Harefield NHS Foundation Trust; Institute... and other collaboratorsRecruitingLung Cancer | Lung Metastases | Indeterminate Pulmonary Nodules | Second Primary CancerUnited Kingdom
-
Zhejiang Cancer HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang University; First... and other collaboratorsUnknownHepatocellular Carcinoma | Pulmonary Metastasis
-
Memorial Sloan Kettering Cancer CenterCompletedLung Metastases | Endobronchial Metastases | Pleural Metastases | Mediastinal MetastasesUnited States
-
Maria Sklodowska-Curie National Research Institute...RecruitingSoft Tissue Sarcoma | Pulmonary MetastasisPoland
-
Institut BergoniéGroupement Interrégional de Recherche Clinique et d'InnovationCompletedNeoplastic Cells, Circulating | Colo-rectal Cancer | Circulating Tumor Cell | Pulmonary Metastasis | Immune Evasion, TumorFrance
Clinical Trials on Intraoperative intracavitary lung ultrasonography
-
Case Comprehensive Cancer CenterCompleted
-
Barnes Retina InstituteUnknownUveal MelanomaUnited States
-
The Cleveland ClinicTerminatedQuality of Life | Fibroid UterusUnited States
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
Bursa Yüksek İhtisas Education and Research HospitalCompleted
-
University Hospital, CaenCompletedUltrasonography | Education | General PracticeFrance
-
Assiut UniversityRecruitingCOVID-19 PneumoniaEgypt
-
Centre hospitalier de l'Université de Montréal...RecruitingVentilator-Induced Lung Injury | Mechanical Ventilation ComplicationCanada
-
University Hospital, CaenCompletedLower Resp Tract Infection | Ultrasound Therapy; ComplicationsFrance
-
Kırıkkale UniversityEnrolling by invitationSuspected Damage to Fetus From Other Disease in the Mother, Affecting Management of Mother, With Delivery | Patient Death or Serious Disability Associated With A Haemolytic Reaction Due to the Administration of ABO-Incompatible Blood or Blood ProductsTurkey